Blog Archives

Objective Motion Sensor Assessment Highly Correlated with Scores of Global Levodopa-Induced Dyskinesia in Parkinson’s Disease

T. Mera, M. Burack, J. Giuffrida J Parkinsons Dis. 2013 Jan 1;3(3):399-407.

Tagged with: , , , , , ,

Quantitative assessment of levodopa-induced dyskinesia using automated motion sensing technology

T. Mera, M. Burack, J. Giuffrida Conf Proc IEEE Eng Med Biol Soc. 2012.

Tagged with: , , , ,

PRESS RELEASE: The University of Rochester and Great Lakes NeuroTechnologies launch new clinical study to develop ambulatory dyskinesia assessment system

VIEW PRESS RELEASE [PDF] Cleveland, OH – August 15, 2011 – Great Lakes NeuroTechnologies’ KinetiSense motion sensor technology will be used in a clinical study to capture and quantify dyskinesias (involuntary, irregular movements) caused by Parkinson’s disease (PD) medication. PD

Tagged with: , , , , , , , , , , , , , , ,